SPATA6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.79349893112158E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.366130E-04 |
Normal-vs-Stage2 |
2.4835999999917E-05 |
Normal-vs-Stage3 |
3.85247389544929E-14 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
1.436760E-01 |
Stage1-vs-Stage3 |
4.7300000027839E-08 |
Stage1-vs-Stage4 |
4.90799623165117E-11 |
Stage2-vs-Stage3 |
1.176240E-02 |
Stage2-vs-Stage4 |
4.220400E-04 |
Stage3-vs-Stage4 |
1.722180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.41260386405429E-11 |
Normal-vs-AfricanAmerican |
1.29810000004671E-06 |
Normal-vs-Asian |
8.947200E-01 |
Caucasian-vs-AfricanAmerican |
3.455000E-01 |
Caucasian-vs-Asian |
7.680300E-02 |
AfricanAmerican-vs-Asian |
6.890200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.97137878138665E-12 |
Normal-vs-Female |
7.24299999976807E-07 |
Male-vs-Female |
3.359600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.697560E-03 |
Normal-vs-Age(41-60Yrs) |
1.13379999833185E-08 |
Normal-vs-Age(61-80Yrs) |
7.31330551673182E-11 |
Normal-vs-Age(81-100Yrs) |
2.956500E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.650800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.507600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.142600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.112200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.855600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.852800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.059000E-01 |
Normal-vs-Grade 2 |
3.185000E-04 |
Normal-vs-Grade 3 |
6.26054763586126E-13 |
Normal-vs-Grade 4 |
1.62436730732907E-12 |
Grade 1-vs-Grade 2 |
4.617500E-02 |
Grade 1-vs-Grade 3 |
1.042180E-04 |
Grade 1-vs-Grade 4 |
8.14099998525109E-09 |
Grade 2-vs-Grade 3 |
1.97349999997432E-06 |
Grade 2-vs-Grade 4 |
3.79696274421804E-14 |
Grade 3-vs-Grade 4 |
2.28219999999224E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.874400E-02 |
Normal-vs-ccB subtype |
1.63813407283442E-12 |
ccA subtype-vs-ccB subtype |
6.89559520594685E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.88660017900133E-10 |
Normal-vs-N1 |
7.241200E-04 |
N0-vs-N1 |
7.079600E-02 |
|
|